The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
about
Cefepime-associated status epilepticus in an ICU patient with renal failure.Reversible encephalopathy induced by cefoperazone: a case report monitored with EEG.Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.Drug therapy in patients with chronic renal failure.Neurotoxic effects associated with antibiotic use: management considerationsCefepime neurotoxicity in patients with renal insufficiencyConsensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in?Cefepime: a reappraisal in an era of increasing antimicrobial resistance.Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring.Management of meningitis due to antibiotic-resistant Acinetobacter species.Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?Neuropsychiatric complications of chronic kidney disease.Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Central nervous system syndromes in solid organ transplant recipients.Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: case report, pharmacokinetic modeling, and review of the literature.Predominant Jaw Myoclonus from Cefepime Toxicity: A Case Report and a Review of the LiteratureNeurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review.Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature.The clinical heterogeneity of drug-induced myoclonus: an illustrated review.Cefepime and amikacin as empirical therapy in patients with febrile neutropaenia: a single-centre phase II prospective survey.Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness.Clinical Reasoning: An 87-year-old man with chronic obstructive pulmonary disease and acute encephalopathy.Convulsive liability of cefepime and meropenem in normal and corneal kindled mice.Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!Antibiotic-induced neurotoxicity in dialysis patients: a retrospective study.Cefepime-induced neurotoxicity: a systematic review.Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem.Cefepime-induced neurotoxicity in a pediatric patient on chronic hemodialysis: a case report.A Physiologically Based Pharmacokinetic Perspective on the Clinical Utility of Albumin-Based Dose Adjustments in Critically Ill Patients.Cefepime neurotoxicity can mimic postanoxic coma with myoclonic status epilepticus.
P2860
Q30448809-1EF25C55-E598-431A-99E0-C0503B1E4F50Q33159287-8E25F06F-DB90-434C-9A21-FDEB861DB13BQ33754773-84768247-6599-4CAF-86D9-5E284C4EEC0EQ34150967-EB657AD5-BDAC-4119-9962-5C54A6D621CCQ34206012-E0DD4A4C-5A0F-424F-9FAF-37558974DA20Q35219637-16F30760-DBF6-4A56-8727-C00CCBF1DFE4Q35843551-5214A144-D116-4FA8-A50E-9085E210B938Q36474366-A3B036F5-C3DA-4FA6-9DBF-48D144460A52Q36667925-FEC3C9F2-046E-4C4A-BF14-D1B9B0F1048CQ37079350-30072A32-4E30-4650-A479-68BB835B4FD4Q37334702-F7F54840-0AB6-4F9B-8B23-B7011603C670Q37382976-75A761DC-E0A3-4291-B3F4-31B01D00BDDEQ37516599-2BBDE9EE-8E08-46D9-BE71-99C7624FD07BQ37766749-603C2047-252D-4086-A015-6AAFA1277C04Q37771799-2516DFF9-399F-48E2-A2AC-06C97B7BA962Q38004063-534AEAD5-4F53-48D2-A4EF-50630E694A2AQ38219391-F6FF5425-BEA3-48E3-97EE-8B6B0AB5B17CQ38232834-C4759BDA-08D9-44FB-90B8-518B560479EDQ38594298-4CF83241-6B5A-4B51-BA2A-E54E4719A336Q38654209-3260DA11-DBBE-412A-96DE-6EDC6BE98199Q38826267-D72005DF-96D9-42E5-AB10-049F7D084E67Q39040815-BA859A50-A2E9-4846-89FB-57C1B65693ADQ40393915-32160862-B82A-4FE5-876B-7BBCADE1AC75Q40472274-70151465-3C00-4B66-A346-1C5154B94CD1Q41532998-6A56EF59-A5C7-4C91-948E-43A1965BF52DQ41849515-E682250A-5D6E-4B47-8735-20D023E706B2Q43107473-FC2F0CF5-10B4-4CF9-B8D5-91377A149076Q43870295-DDBBB392-96DC-4C9B-A379-B97AAFED1625Q43915417-D4D008C4-72EF-467C-A0DD-B5CDD7CE085EQ45171686-997299CE-6EAE-4DD9-8804-A1A9004BC671Q47281419-82D4F8CE-E7A4-468B-AD0A-96A82B5E8362Q48154458-9073C036-C57C-4DB3-8F35-BDC7781E8175Q50006823-14947F4C-99DB-4BBC-996C-42E116C51233
P2860
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
@en
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
@nl
type
label
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
@en
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
@nl
prefLabel
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
@en
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
@nl
P2093
P356
P1476
The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
@en
P2093
P304
P356
10.1093/NDT/GFM713
P407
P577
2008-01-05T00:00:00Z